Capacity scale-ups to drive Epigral's ₹5,000 crore target by FY31: CMD
The company expects to reach ₹2,900 crore in revenue this fiscal year following revenue of ₹2,500-2,530 crore in 2026
We haven't written up this one. Business Standard IN has the full story — the link below goes straight to it.